002898SZSE

Special Explanation on Proposed No Profit Distribution for 2025

*ST Sailong Co., Ltd.·April 30, 2026

✨ AI Summary

The announcement outlines that SAILONG Pharmaceutical Group Co., Ltd. plans not to distribute profits for the fiscal year 2025, including no cash dividends or stock bonuses. This decision is based on a net loss of approximately 121 million yuan and negative retained earnings. The proposal will be submitted for approval at the 2025 annual shareholders' meeting.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Securities Code: 002898
Securities Abbreviation: *ST SAILONG
Announcement Number: 2026-045

SAILONG Pharmaceutical Group Co., Ltd. Special Explanation on Proposed No Profit Distribution for 2025

The company and all members of the board of directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

Special Reminder:

The profit distribution plan for SAILONG Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") for 2025 is as follows: no cash dividends, no stock bonuses, and no capital reserve fund transfers to increase share capital.
The profit distribution plan for 2025 is subject to approval at the 2025 annual shareholders' meeting.

I. Review Procedure
The Company held the 25th meeting of the 4th Board of Directors on April 29, 2026, where the proposal on the profit distribution plan for 2025 was approved and is intended to be submitted to the 2025 annual shareholders' meeting for review.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.